Glitaris 15 Tablet
Marketer
Eris Lifesciences Ltd
Salt Composition
Pioglitazone (15mg)
Overview Glitaris 15 Tablet
DiabetiCare 15mg tablets manage type 2 diabetes in adults by regulating blood glucose. This helps prevent serious diabetic complications such as vision impairment and kidney disease. DiabetiCare 15mg may be prescribed alone or with other medications, with or without food, consistently at the same time daily for optimal effect. Dosage is determined and adjusted by your physician based on individual response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose, potentially leading to nerve damage, kidney failure, blindness, and limb loss. This medication is part of a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include headache, sinus inflammation, myalgia, and sore throat. Report persistent or bothersome side effects to your doctor. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney impairment. Inform your physician of any history of heart, thyroid, or endocrine disorders before use, as suitability may be affected. Pregnant or lactating individuals should seek medical advice prior to use. Regular blood glucose monitoring is necessary, and your physician may order blood tests to assess blood cell counts and liver function.
Uses of Glitaris 15 Tablet
Managing Type 2 diabetes
Major Benefits of Glitaris 15 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glitaris 15 Tablet whole; avoid chewing, crushing, or breaking it. Consumption with or without food is acceptable, but consistent timing is recommended.
Common Side effects of Glitaris 15 Tablet:
- Headache
- Sore throat
- Sinus inflammation
- Muscle pain
How to use Glitaris 15 Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glitaris 15 Tablet can be consumed with or without food, though consistent timing is recommended.
How Glitaris 15 Tablet works:
Glycemic control is achieved with Glitaris 15 Tablet, an antidiabetic agent that enhances the body's responsiveness to insulin, thereby regulating blood glucose.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Glitaris 15 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glitaris 15 Tablet during pregnancy may pose risks. While human research is insufficient, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCAUTION
Use of Glitaris 15 Tablet during lactation requires careful consideration. Breastfeeding should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system. Close monitoring of the infant's blood glucose levels is advised while the mother is taking Glitaris 15 Tablet.
DrivingSAFE
Driving ability is typically unaffected by Glitaris 15 Tablet.
KidneySAFE IF PRESCRIBED
Use of Glitaris 15 Tablet is considered safe for individuals with kidney impairment. No modification to the Glitaris 15 Tablet dosage is necessary.
LiverCAUTION
Patients with liver impairment should use Glitaris 15 Tablet cautiously, potentially requiring a modified dosage. Consult your physician for guidance. Glitaris 15 Tablet is contraindicated for individuals with advanced hepatic dysfunction.
What if you forget to take Glitaris 15 Tablet :
Omit any missed dose of Glitaris 15 Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glitaris 15 Tablet
| Label | Value |
|---|---|
| Chemical Category | Thiazolidinedione-based compound |
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
| Actions | PPARγ agonist (thiazolidinedione) |






